Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.39
Delayed Data
As of 3:59pm ET
 +0.06 / +0.95%
Today’s Change
4.03
Today|||52-Week Range
7.80
+9.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues9.3M6.3M9.5M11.8M
 
 
 
 
 
Cost of Goods Sold5.7M19.0M26.0M5.1M
 
 
 
 
 
Depreciation And Amortization259.0K256.0K229.0K229.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.3M-12.9M-16.7M6.5M
 
 
 
 
 
General Expenses27.0M28.9M29.0M29.6M
 
 
 
 
 
Other Operating Expenses0.000.00-11.8M0.00
 
 
Research And Development7.0M8.7M6.2M6.8M
 
 
 
 
 
Total Operating Expenses32.9M48.2M43.4M34.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.6M-41.8M-33.9M-23.1M
 
 
 
 
 
Extraordinary Charge-2.7M------
 
 
Interest Expense On Debt18.5M0.00--0.00
 
 
Other Expenses7.0K-19.0K1.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.6M-41.7M-33.8M-23.0M
 
 
 
 
 
Income Taxes-20.0K-20.0K-20.0K-20.0K
 
 
 
 
 
Net Income-44.7M-41.7M-33.8M-23.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.8M105.9M106.0M107.1M
 
 
 
 
 
Shares To Calculate EPS Diluted105.8M105.9M106.0M107.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.39-$0.32-$0.21
 
 
 
 
 
EPS Diluted-$0.42-$0.39-$0.32-$0.21